Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Supporting Just-in-Time Consent for Prenatal Screening

Award Number: R01HG013718
ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2025
PERIOD OF PERFORMANCE END DATE: 06/30/2028

Group Awards By:

View Award Description

Supporting Just-in-Time Consent for Prenatal Screening - PROJECT SUMMARY/ABSTRACT Prenatal screening for genetic conditions (PGS) has changed the landscape of prenatal care by offering noninvasive indication of some fetal genetic conditions. PGS should be clearly distinguished from prenatal diagnostic testing using microarray analysis of amniotic fluid, which is considered the gold standard for fetal genetic assessment. While other routine screens are not held to the standard of fully informed consent, the ethics literature on PGS, from maternal serum screening to cell-free DNA and other technologies, has argued that PGS requires higher levels of consent based on the exceptional nature of its informational impacts, including potential abortion decisions based on fetal characteristics. Multiple studies examining the patient experience have described or proactively expressed concern at the routinization of PGS, including insufficient pre-test counseling and ethical reflection on whether PGS was the right approach for the patient and family, consistent with their values on disability and abortion. However, our own research on the implementation of PGS in low-resource settings in the U.S. has found that there are few resources to attempt, let alone achieve, fully informed consent prior to screening. Furthermore, for the great majority of pregnancies that do not receive a high-probability PGS screen, attempting fully informed consent introduces mental and psychological stress on pregnant individuals that may be unnecessary and undesirable. Patients who receive screen-positive results do require extensive information and support for pregnancy and parenting decision-making, but they represent a tiny minority of all those screened. Thus, we argue that a model of just-in-time consent (JITC) for PGS, incorporating simple consent with shared decision-making, better fulfills the goals of prenatal screening and locates intense moral decision-making in a more appropriate place in the pregnancy journey. JITC acknowledges the increased moral weight that prenatal screening may have over other routine screens without burdening pregnant individuals and health systems with unnecessary consent procedures. We propose a clinical trial over three demographically and geographically diverse sites that serve a large pregnant population from historically underserved communities to compare a novel JITC mechanism to current care. Our Aims are: (1a) Conduct community engaged research with patients and providers to understand the necessary components of JITC for PGS; (1b) Design and pilot a mobile-based intervention to deliver knowledge elements necessary for JITC for cfDNA; (2) Using a stepped-wedge design, implement the mobile-based intervention at three diverse sites and evaluate outcomes of feasibility and decisional satisfaction; and (3) Develop data-based, ethically informed recommendations regarding implementation of a just-in-time consent model for patients receiving high risk PGS screening test results.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2024	MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)	4500 SAN PABLO RD S	JACKSONVILLE	FL	32224	DUVAL	USA	Human Genome Research	000	1	2/12/2026	NEW	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $774,052 )
2025	2025	CASE WESTERN RESERVE UNIVERSITY	10900 EUCLID AVE	CLEVELAND	OH	44106	CUYAHOGA	USA	Human Genome Research	001	2	9/25/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$774,052
2025	2024	MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)	4500 SAN PABLO RD S	JACKSONVILLE	FL	32224	DUVAL	USA	Human Genome Research	000	1	9/24/2025	NEW	$0
														Subtotal = $774,052

Issue Date FY: 2024 ( Subtotal = $812,285 )
2024	2024	MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)	4500 SAN PABLO RD S	JACKSONVILLE	FL	32224	DUVAL	USA	Human Genome Research	000	1	9/18/2024	NEW	$812,285
														Subtotal = $812,285

Grand Total All Awards = $1,586,337

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Supporting Just-in-Time Consent for Prenatal Screening

Award Number: R01HG013718

ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2025

PERIOD OF PERFORMANCE END DATE: 06/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer